Back to Search
Start Over
Noninferiority of Subcutaneous Versus Intravenous Casirivimab/Imdevimab for Outpatient Treatment of SARS-CoV-2 in a Real-World Setting.
- Source :
- Monoclonal Antibodies in Immunodiagnosis & Immunotherapy; Aug2022, Vol. 41 Issue 4, p210-213, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 21679436
- Volume :
- 41
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Monoclonal Antibodies in Immunodiagnosis & Immunotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 158786814
- Full Text :
- https://doi.org/10.1089/mab.2022.0008